Are lymphocytotoxic iso-antibodies induced by the early human trophoblast?

[Direct arteriovenous fistula in the neck: one of the causes of tinnitus].

Nederlands tijdschrift voor geneeskunde·1989

Oligodendroglioma. A comparison of two grading systems.

Cancer·1988

Effects of nimodipine on EEG and 31P-NMR spectra during and after incomplete forebrain ischemia in the rat.

European journal of pharmacology·1986

[Vascular spasm and cerebral ischemia after meningeal hemorrhage caused by rupture of an aneurysm].

Neuro-Chirurgie·1986

Maturation of a primitive neuroectodermal brain tumor? A case study with some remarks on the classification and nomenclature of 'primitive' CNS tumors.

Clinical neurology and neurosurgery·1986

Nimodipine treatment of ischemic neurological deficits due to cerebral vasospasm after subarachnoid hemorrhage. Clinical results of a multicenter study.

Neurochirurgia·1985

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Review Article: Beyond the Therapeutic Ceiling in Inflammatory Bowel Disease-Mechanism-Based Positioning and Emerging Therapeutic Strategies.

Alimentary pharmacology & therapeutics·2026

Cytologic Sub-Categorization of Bethesda Category IV Nodules Has Significant Clinicopathologic Outcomes.

Cytopathology : official journal of the British Society for Clinical Cytology·2026

Efficient detection of human antigen-specific CD4+ T cells with peptide-exchangeable HLA-DP4 tetramers and multiplexed magnetic enrichment.

Journal of immunological methods·2026

Enhancing Tumor Immunogenicity through Hyaluronic Acid-Mediated Delivery of Nonself Antigenic Peptides.

ACS applied bio materials·2026

Outcomes of early amniotic membrane transplantation in acute ocular thermochemical injuries caused by carbide guns in India.

Indian journal of ophthalmology·2026

Diagnostic challenges posed by the wide morphological and immunophenotypic spectrum of plasma cell neoplasms.

Blood research·2026

Related Experiment Videos

Are lymphocytotoxic iso-antibodies induced by the early human trophoblast?

Related Concept Videos

[Direct arteriovenous fistula in the neck: one of the causes of tinnitus].

Oligodendroglioma. A comparison of two grading systems.

Effects of nimodipine on EEG and 31P-NMR spectra during and after incomplete forebrain ischemia in the rat.

[Vascular spasm and cerebral ischemia after meningeal hemorrhage caused by rupture of an aneurysm].

Maturation of a primitive neuroectodermal brain tumor? A case study with some remarks on the classification and nomenclature of 'primitive' CNS tumors.

Nimodipine treatment of ischemic neurological deficits due to cerebral vasospasm after subarachnoid hemorrhage. Clinical results of a multicenter study.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Review Article: Beyond the Therapeutic Ceiling in Inflammatory Bowel Disease-Mechanism-Based Positioning and Emerging Therapeutic Strategies.

Cytologic Sub-Categorization of Bethesda Category IV Nodules Has Significant Clinicopathologic Outcomes.

Efficient detection of human antigen-specific CD4+ T cells with peptide-exchangeable HLA-DP4 tetramers and multiplexed magnetic enrichment.

Enhancing Tumor Immunogenicity through Hyaluronic Acid-Mediated Delivery of Nonself Antigenic Peptides.

Outcomes of early amniotic membrane transplantation in acute ocular thermochemical injuries caused by carbide guns in India.

Diagnostic challenges posed by the wide morphological and immunophenotypic spectrum of plasma cell neoplasms.

Related Experiment Videos

Are lymphocytotoxic iso-antibodies induced by the early human trophoblast?

Related Concept Videos

Related Articles